bioRxivImmunology
Divergent roles for caspase-8 and MLKL in high-fat diet induced obesity and NAFLD in mice
H. Tye, S. A. Conos, T. M. Djajawi, N. Abdoulkader, I. Y. Kong, H. L. Kaummon, V. K. Narayana, M. Speir, T. A. Gottschalk, J. Emery, D. S. Simpson, C. Hall, A. J. Vince, S. Russo, R. Crawley, M. Rashidi, J. Hildebrand, J. M. Murphy, L. Whitehead, D. P. De Souza, S. L. Masters, E. D. Hawkins, A. J. Murphy, J. Vince, K. Lawlor
Abstract
Cell death frequently occurs in the pathogenesis of obesity and non-alcoholic fatty liver disease (NAFLD). However, the exact contribution of core cell death machinery to disease manifestations remains ill-defined. Here, we show via the direct comparison of mice genetically deficient in apoptotic caspase-8 in myeloid cells, or the essential necroptotic regulators, Receptor-interacting protein kinase-3 (RIPK3) and Mixed lineage kinase domain-like (MLKL), that RIPK3-caspase-8 signaling regulates macrophage inflammatory responses and drives adipose tissue inflammation and NAFLD upon high-fat diet feeding. In contrast, MLKL, divergent to RIPK3, contributes to both obesity and NAFLD in a manner largely independent of inflammation. We also uncover that MLKL regulates the expression of molecules involved in lipid uptake, transport and metabolism and, congruent with this, we discover a shift in the hepatic lipidome upon MLKL deletion. Collectively, these findings highlight MLKL as an attractive therapeutic target to combat the growing obesity pandemic and metabolic disease.
- organism: mouse
- research focus: host-pathogen & immune response
- research focus: metabolism & bioenergetics
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Therapeutic knockdown of MLKL reduces diet-induced obesity and improves insulin signalling in mature adipocytes
Masaaki Sato, Xichun Lee, … Denuja Karunakaran·AtherosclerosisPeer-reviewed·Aug 1, 2026
- Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High Fat, High Fructose, High Cholesterol Diet Mouse Model
P. Ohene-Marfo, H. V. M. Nguyen, … S. S. Deepa·bioRxiv·Jan 10, 2024
- Role of Mcpip1 in obesity-induced hepatic steatosis as determined by myeloid and liver-specific conditional knockouts.
Natalia Pydyn, Dariusz Żurawek, … Jerzy Kotlinowski·FEBS JournalPeer-reviewed·May 31, 2021
- RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages
- Hepatocyte MLKL Drives Obesity-Driven Hepatocellular Carcinoma Progression via Mitochondrial Dysfunction Independent of Necroptosis in MASLD
Phoebe Ohene-Marfo, Sabira Mohammed, … Sathyaseelan S. Deepa·HepatologyPeer-reviewed·Aug 4, 2026
- MKP1 promotes nonalcoholic steatohepatitis by suppressing AMPK activity through LKB1 nuclear retention
B. Qiu, A. Lawan, … A. M. Bennett·bioRxiv·Jul 10, 2023